Retire Through Ownership Act: ESOP Valuation in 2026
The October 2026 ESOP valuation amendment: verified enactment, good-faith reliance, continuing fiduciary duties and questions for a pending transaction.
Oct 20, 2026
Valuation drives every negotiation that follows it. These guides cover how multiples vary by industry, the difference between SDE and EBITDA-based valuation, and where buyers and sellers commonly disagree on price.
Business Valuation Tool →9 articles in this category.
The October 2026 ESOP valuation amendment: verified enactment, good-faith reliance, continuing fiduciary duties and questions for a pending transaction.
Oct 20, 2026
How RIA firms are valued: revenue and EBITDA multiples, DCF, valuation drivers, and the earnout, escrow, and indemnification terms that change the real price.
Jul 21, 2026
A detailed legal analysis of contingent value rights in pharma M&A: regulatory and sales milestone triggers, commercially reasonable efforts obligations, tax treatment, SEC registration, CVR trustee duties, and litigation risk under Delaware law.
Apr 18, 2026
Business valuation multiples vary significantly by industry. This guide explains how HVAC, cleaning, landscaping, plumbing, electrical, restaurant, and professional services businesses are priced, and what drives multiple expansion or compression.
Apr 17, 2026
SaaS companies are valued on revenue multiples, not EBITDA. This guide explains the metrics that drive those multiples: ARR, NRR, Rule of 40, CAC payback, gross margin, customer concentration, contract length, churn, and deferred revenue mechanics at close.
Apr 17, 2026
Compare SDE and EBITDA in a business acquisition: verify add-backs, replacement costs and the price basis before an unclear metric changes the deal.
Apr 17, 2026
How to value a Michigan business: income, market, and asset approaches. Industry multiples for Detroit manufacturing, professional services, healthcare, and tech companies.
Jan 31, 2025
Business valuation for M&A: SDE vs EBITDA, industry multiples, DCF, QoE adjustments, and how buyers and sellers price acquisitions. From experienced M&A counsel.
A detailed legal analysis of fair market value determination, price-setting mechanisms, and ILPA guidance for GP-led continuation fund transactions: competitive auction process, independent valuation, fairness opinions, LPAC consent, SEC conflicts disclosure, discount and premium to NAV analysis, fee allocation, and record-keeping for conflicts defense.
We engage selectively with clients who value thorough counsel. Senior attorney Alex Lubyansky leads every matter.
Before you go
Talk through your transaction with Alex Lubyansky at no cost. Submit your transaction details and the team will confirm next steps.
Request Your Free ConsultationOr call (248) 266-2790